The serotonin transporter (SERT) has been implicated in a variety of neuropsychiatric
disorders including depression, schizophrenia, substance abuse, alcoholism, and …

The serotonin transporter (SERT) has been implicated in a variety of neuropsychiatric
disorders including depression, anxiety, and suicide, and is the target of the selective …

The serotonin reuptake or transporter sites (SERT) are located specifically on the terminals
and cell bodies of the serotonergic neurotransmission system in the brain. They are the …

N, N-Dimethyl-2-(2′-amino-4′-hydroxymethylphenylthio) benzylamine (38), substituted on
ring A, was reported to display high binding affinity and selectivity to the human brain …

The recent introduction of a number of new radiotracers suitable for imaging the serotonin
transporters (SERT) has radically changed the field of SERT imaging. Whereas, until …

A series of four 2-(phenylthio) araalkylamines have been radiolabeled with 11C and
evaluated as potential radiotracers for imaging the serotonin transporter (SERT) by positron …

The synthesis, radiolabeling, and in vitro and in vivo evaluation of a new positron emission
tomography (PET) radioligand for the serotonin transporter (SERT),[11C] 2-[2 …

PET of the serotonin transporter (SERT) in the brain is a useful tool for examining normal
physiologic functions as well as disease states involving the serotonergic system. The goal …

INTRODUCTION: Single photon emission computed tomography (SPECT) imaging of the
serotonin transporter (SERT) in the brain is a useful tool for examining normal physiological …

As the serotonin transporter (SERT) is involved in several neurodegenerative and
psychiatric disorders, radiopharmaceuticals to image the SERT by PET or SPECT would be …